MCK
MCKESSON CORP
Key Financials
Net Income
$4.8B
↑ 44.5%
Operating Income
$6.2B
↑ 40.5%
Revenue
$403.4B
↑ 12.4%
Gross Profit
$14.6B
↑ 9.2%
Total Assets
$82.3B
↑ 9.6%
Shareholders' Equity
$-2172000000.00
↓ 4.7%
EPS (Diluted)
$38.38
↑ 49.2%
Long-term Debt
$6.5B
↑ 15.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 5/8/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| 8-K | 4/28/2026 | View on SEC |
| 3 | 4/13/2026 | View on SEC |
| 8-K | 4/6/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/6/2026 | View on SEC |
| 8-K | 3/5/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MCK |
| Company Name | MCKESSON CORP |
| CIK | 927653 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | 972-446-4800 |